Nordic Bone
ABOUT USINVESTORSPIPELINENEWSCAREERSCONTACT

Press Releases

August 2, 2010

Osteologix and Servier Announce ex-US Licensing Agreement

February 8, 2010

Osteologix to Present at 12th Annual BIO CEO & Investor Conference

January 11, 2010

Osteologix to Present at Biotech Showcase 2010

January 4, 2010

Osteologix Announces Financing

December 9, 2009

Osteologix Inc. Announces Plans to File for European Marketing Authorization for Proprietary Osteoporosis Drug

October 27, 2009

Osteologix to Present at 8th Annual Bio Investor Forum

October 20, 2009

Hope on World Osteoporosis Day – New Drug in Development

Osteologix, Inc. Continues Development of NB S101 for Osteoporosis

September 8, 2009

Osteologix to Highlight Osteoporosis Drug Opportunity at the Rodman and Renshaw 11th Annual Healthcare Conference

August 24, 2009

Osteologix Receives Positive Decision to Grant A Patent for Key Osteoporosis Drug Patent in Japan

May 27, 2009

Osteologix Receives Key U.S. Patent Allowance for Novel Osteoporosis Drug

May 19, 2009

Osteologix Receives U.S. Patent Allowance for Osteoporosis Drug Manufacturing Patent

March 30, 2009

Osteologix Prevails in European Patent Opposition for Osteoporosis Drug

EPO Division Finds Use of NB S101 Novel with Superior Bioavailability Over Protelos®